Pharmaceutical Strategy Analysis l Report Store l Pharma Intelligence

CMOs in China and India: Still the Places to be?

Low-cost and skilled workforces in China and India have positioned both countries as increasingly important manufacturing hubs for pharmaceutical companies, as they seek to contain costs while retaining quality outsourcing partners.

Despite the apparent inevitability of the contract manufacturing organization (CMO) sector’s growth in China and India, a recent wave of scandals has put significant dents in the reputations of both countries as locations for foreign firms to manufacture drugs. Rising costs have also caused some firms to question whether using one of the region’s many CMOs is worth the risk.

Strategy analysis

CMOs in China and India: Still the Places to be?

Q4 2016 Outlook Report

Gastric Cancer KOL Interview – US

Japan Regulatory Issues

Post-AASLD US KOL Interview

Key Potential Drug Launches in 2020

France Regulatory Issues

Human Papillomavirus (HPV) KOL Interview – US, Midwest

CER, HEOR, and Value-Based Frameworks in the US

Multiple Sclerosis KOL Insight Interview

Biosimilars Portfolio and Pipeline Trends, 2016

Key Trends in European Market Access

Non-Small Cell Lung Cancer (NSCLC) KOL Interview – US

Access Trends in Emerging Markets

Datamonitor Healthcare Multiple Myeloma KOL Interview – UK

SGLT-2 Pulse Survey

2014 October Dermatology Survey

Value-Based Reimbursement in the US

Chronic Lymphocytic Leukemia (CLL) KOL Interview – Germany

The Evolution of Pharmaceutical Sales Strategies Continues

Gene Therapy Pipeline and Portfolio Analysis

Head and Neck Cancer KOL Interview – US, Southeast

Post-AAIC KOL Interview

Oncology Pathways in the US – Friend or Foe for Pharma

Schizophrenia and Bipolar Disorder KOL Interview – Germany

Multiple Sclerosis (MS) KOL Interview – UK, London

Parkinson’s Disease KOL Interview – US, South

Chronic Heart Failure Pricing, Reimbursement, and Access

Crohn’s Disease KOL Interview – US, Northeast

Leading Players in the CMO Market